MVS Pharma
Active Risk: not assessedSummary
MVS Pharma is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
History
Acts, filings and financial milestones
2026
03-08
Gazette deed
IncorporationAppointments: VAN STEENBERGE Maaike Karien Chris (director) and BARCZUK Sam Gerard Etienne (director) · Founder · Founding capital8 facts ▸
Gazette deed
Incorporation
Appointments: VAN STEENBERGE Maaike Karien Chris (director) and BARCZUK Sam Gerard Etienne (director) · Founder · Founding capital8 facts ▸
- Incorporation, 28-07-2026
- Founder, VAN STEENBERGE Maaike Karien Chris (sole founder)
- Founding capital, €3,000
- Bank account, “[redacted]”, 3000 (deed in Dutch)
- Registered office clause, “9860 Oosterzele (Balegem), Waterrad 1 A000” (deed in Dutch)
- Director appointment, VAN STEENBERGE Maaike Karien Chris (director (not named in the articles))
- Director appointment, BARCZUK Sam Gerard Etienne (director (not named in the articles))
- Pre-incorporation commitments, “takeover, de rechten en verbintenissen overneemt die voortvloeien uit de rechtshandelingen die in haar naam en voor haar rekening werden gesteld vóór de opricht…” (deed in Dutch)
Gazette deed
1 of 1 deed read